Resolution Therapeutics to present EMERALD study design at the British Association for the Study of the Liver (BASL) annual meeting 2025

– EMERALD Chief Investigator Prof. Jonathan Fallowfield will present the poster on study design
– EMERALD is a multicentre Phase I/II study evaluating Resolution’s…